Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 study evaluating anlotinib hydrochloride capsule with AK105 in advanced gastric and gastro-oesophageal junction adenocarcinoma is in…
-
CLINICAL_TRIALS trial_result · 2020-05-11Clinical Trial Update: A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adenocarcinoma [Phase 1, Phase 2]
A Phase 1b/2 trial evaluating MEDI4736 (durvalumab) with tremelimumab, MEDI4736 alone, or tremelimumab alone in gastric or gastroesophageal …
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers [Phase 1]
A Phase 1 pilot study evaluating the safety and feasibility of adding FOLFIRINOX chemotherapy to neoadjuvant radiation for gastric and gastr…
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer [Phase 2]
Phase 2 trial evaluating perioperative chemotherapy plus PD-1 antibody for gastric cancer; efficacy and safety data not yet reported in the …
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection [Phase 3]
Phase 3 trial evaluating capecitabine versus observation after R0 resection in certain gastric cancer patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer [Phase 2]
Phase 2 study evaluating camrelizumab in combination with docetaxel and S-1 as adjuvant therapy for stage III gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer [Phase 2]
A Phase 2 clinical trial update evaluating camrelizumab plus apatinib and tegio in first-line refractory patients with advanced gastric canc…
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial update on hyperthermic intraperitoneal chemotherapy (HIPEC) for locally advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-25Clinical Trial Update: Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial [Phase 3]
Phase III randomized trial evaluating adjuvant chemotherapy with S-1 versus S-1/Oxaliplatin with or without radiotherapy for completely rese…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating radical gastrectomy with hyperthermic intraperitoneal chemotherapy (HIPEC) for locally advanced gastric ca…
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer [Phase 3]
Phase 3 trial updating adjuvant chemotherapy with Nab-paclitaxel plus S-1 for stage III gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: mFLOT Chemotherapy as First-line Treatment in GC [Phase 1, Phase 2]
Clinical trial update on mFLOT chemotherapy as first-line treatment for gastric cancer, including Phase 1 and Phase 2 results.
-
FDA label_change · 2020-03-19FDA Approved: ONTRUZANT — Supplemental Application (Organon LLC)
FDA approves a supplemental application for ONTRUZANT (trastuzumab) filed by Organon LLC, resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 open-label dose-finding study evaluated the safety and pharmacokinetics of FPA144 in patients with advanced solid tumors, inclu…
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer [Phase 3]
Phase 3 clinical trial update on lymph node dissection (14v) in clinically advanced gastric cancer (T3N+, T4N+).
-
CLINICAL_TRIALS trial_result · 2020-03-02Clinical Trial Update: Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer [Phase 3]
Phase 3 trial evaluating the DOS regimen (Docetaxel, Oxaliplatin, S-1) as neoadjuvant chemotherapy for advanced gastric cancer; results post…
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating albumin-paclitaxel combined with apatinib and camrelizumab in advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer [Phase 1, Phase 2]
Phase Ib/2 trial evaluating Fruquintinib in combination with Paclitaxel for advanced gastric cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Perioperative Chemotherapy for Potentially Resectable Gastric Cancer [Phase 2, Phase 3]
Clinical trial update on perioperative chemotherapy for potentially resectable gastric cancer spanning Phase 2 and Phase 3 completed.
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction [Phase 2]
Phase 2 trial evaluating conversion therapy with sintilimab plus CAPOX in unresectable locally advanced or limited metastatic stomach/EGJ ad…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma. [Phase 2]
A Phase 2 clinical trial evaluating sintilimab in combination with Xelox as neoadjuvant therapy for resectable locally advanced gastric or g…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) [Phase 2]
Phase 2 trial evaluating preoperative chemotherapy and chemoradiotherapy for adenocarcinoma of the stomach and gastroesophageal junction has…
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors [Phase 1]
Phase 1 trial evaluating PEGPH20 with pembrolizumab in hyaluronan-high tumors including non-small cell lung cancer and gastric cancer; study…
-
CLINICAL_TRIALS trial_result · 2020-02-06Clinical Trial Update: Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric Cancer [Phase 2]
Phase 2 trial update investigating camrelizumab combined with apatinib, paclitaxel-albumin, and S-1 for gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-06Clinical Trial Update: Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial update evaluating neoadjuvant chemotherapy with paclitaxel-albumin and S-1 for advanced gastric cancer.